Copyright Reports & Markets. All rights reserved.

Global (United States, European Union and China) Sickle Cell Disease Drug Market Research Report 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Sickle Cell Disease Drug Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 ARQ-092
      • 1.3.3 BIVV-003
      • 1.3.4 CAL-H
      • 1.3.5 CTX-001
      • 1.3.6 DRX-194
      • 1.3.7 Others
    • 1.4 Market Segment by Application
      • 1.4.1 Global Sickle Cell Disease Drug Market Share by Application (2019-2025)
      • 1.4.2 Hospital
      • 1.4.3 Clinic
      • 1.4.4 Others
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Global Sickle Cell Disease Drug Market Size
      • 2.1.1 Global Sickle Cell Disease Drug Revenue 2014-2025
      • 2.1.2 Global Sickle Cell Disease Drug Sales 2014-2025
    • 2.2 Sickle Cell Disease Drug Growth Rate by Regions
      • 2.2.1 Global Sickle Cell Disease Drug Sales by Regions 2014-2019
      • 2.2.2 Global Sickle Cell Disease Drug Revenue by Regions 2014-2019
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Sickle Cell Disease Drug Sales by Manufacturers
      • 3.1.1 Sickle Cell Disease Drug Sales by Manufacturers 2014-2019
      • 3.1.2 Sickle Cell Disease Drug Sales Market Share by Manufacturers 2014-2019
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Sickle Cell Disease Drug Revenue by Manufacturers (2014-2019)
      • 3.2.2 Sickle Cell Disease Drug Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Sickle Cell Disease Drug Market Concentration Ratio (CR5 and HHI)
    • 3.3 Sickle Cell Disease Drug Price by Manufacturers
    • 3.4 Key Manufacturers Sickle Cell Disease Drug Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Sickle Cell Disease Drug Market
    • 3.6 Key Manufacturers Sickle Cell Disease Drug Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Sales and Revenue for Each Type
      • 4.1.1 ARQ-092 Sales and Revenue (2014-2019)
      • 4.1.2 BIVV-003 Sales and Revenue (2014-2019)
      • 4.1.3 CAL-H Sales and Revenue (2014-2019)
      • 4.1.4 CTX-001 Sales and Revenue (2014-2019)
      • 4.1.5 DRX-194 Sales and Revenue (2014-2019)
      • 4.1.6 Others Sales and Revenue (2014-2019)
    • 4.2 Global Sickle Cell Disease Drug Sales Market Share by Type
    • 4.3 Global Sickle Cell Disease Drug Revenue Market Share by Type
    • 4.4 Sickle Cell Disease Drug Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Sickle Cell Disease Drug Sales by Application

    6 United States

    • 6.1 United States Sickle Cell Disease Drug Breakdown Data by Company
    • 6.2 United States Sickle Cell Disease Drug Breakdown Data by Type
    • 6.3 United States Sickle Cell Disease Drug Breakdown Data by Application

    7 European Union

    • 7.1 European Union Sickle Cell Disease Drug Breakdown Data by Company
    • 7.2 European Union Sickle Cell Disease Drug Breakdown Data by Type
    • 7.3 European Union Sickle Cell Disease Drug Breakdown Data by Application

    8 China

    • 8.1 China Sickle Cell Disease Drug Breakdown Data by Company
    • 8.2 China Sickle Cell Disease Drug Breakdown Data by Type
    • 8.3 China Sickle Cell Disease Drug Breakdown Data by Application

    9 Rest of World

    • 9.1 Rest of World Sickle Cell Disease Drug Breakdown Data by Company
    • 9.2 Rest of World Sickle Cell Disease Drug Breakdown Data by Type
    • 9.3 Rest of World Sickle Cell Disease Drug Breakdown Data by Application
    • 9.4 Rest of World Sickle Cell Disease Drug Breakdown Data by Countries
      • 9.4.1 Rest of World Sickle Cell Disease Drug Sales by Countries
      • 9.4.2 Rest of World Sickle Cell Disease Drug Revenue by Countries
      • 9.4.3 Japan
      • 9.4.4 Korea
      • 9.4.5 India
      • 9.4.6 Southeast Asia

    10 Company Profiles

    • 10.1 Acceleron Pharma Inc
      • 10.1.1 Acceleron Pharma Inc Company Details
      • 10.1.2 Company Description and Business Overview
      • 10.1.3 Sales, Revenue and Market Share of Sickle Cell Disease Drug
      • 10.1.4 Sickle Cell Disease Drug Product Introduction
      • 10.1.5 Acceleron Pharma Inc Recent Development
    • 10.2 Addmedica SAS
      • 10.2.1 Addmedica SAS Company Details
      • 10.2.2 Company Description and Business Overview
      • 10.2.3 Sales, Revenue and Market Share of Sickle Cell Disease Drug
      • 10.2.4 Sickle Cell Disease Drug Product Introduction
      • 10.2.5 Addmedica SAS Recent Development
    • 10.3 Angiocrine Bioscience Inc
      • 10.3.1 Angiocrine Bioscience Inc Company Details
      • 10.3.2 Company Description and Business Overview
      • 10.3.3 Sales, Revenue and Market Share of Sickle Cell Disease Drug
      • 10.3.4 Sickle Cell Disease Drug Product Introduction
      • 10.3.5 Angiocrine Bioscience Inc Recent Development
    • 10.4 Annexin Pharmaceuticals AB
      • 10.4.1 Annexin Pharmaceuticals AB Company Details
      • 10.4.2 Company Description and Business Overview
      • 10.4.3 Sales, Revenue and Market Share of Sickle Cell Disease Drug
      • 10.4.4 Sickle Cell Disease Drug Product Introduction
      • 10.4.5 Annexin Pharmaceuticals AB Recent Development
    • 10.5 ArQule Inc
      • 10.5.1 ArQule Inc Company Details
      • 10.5.2 Company Description and Business Overview
      • 10.5.3 Sales, Revenue and Market Share of Sickle Cell Disease Drug
      • 10.5.4 Sickle Cell Disease Drug Product Introduction
      • 10.5.5 ArQule Inc Recent Development
    • 10.6 Bio Products Laboratory Ltd
      • 10.6.1 Bio Products Laboratory Ltd Company Details
      • 10.6.2 Company Description and Business Overview
      • 10.6.3 Sales, Revenue and Market Share of Sickle Cell Disease Drug
      • 10.6.4 Sickle Cell Disease Drug Product Introduction
      • 10.6.5 Bio Products Laboratory Ltd Recent Development
    • 10.7 Bioverativ Inc
      • 10.7.1 Bioverativ Inc Company Details
      • 10.7.2 Company Description and Business Overview
      • 10.7.3 Sales, Revenue and Market Share of Sickle Cell Disease Drug
      • 10.7.4 Sickle Cell Disease Drug Product Introduction
      • 10.7.5 Bioverativ Inc Recent Development
    • 10.8 bluebird bio Inc
      • 10.8.1 bluebird bio Inc Company Details
      • 10.8.2 Company Description and Business Overview
      • 10.8.3 Sales, Revenue and Market Share of Sickle Cell Disease Drug
      • 10.8.4 Sickle Cell Disease Drug Product Introduction
      • 10.8.5 bluebird bio Inc Recent Development
    • 10.9 Bristol-Myers Squibb Co
      • 10.9.1 Bristol-Myers Squibb Co Company Details
      • 10.9.2 Company Description and Business Overview
      • 10.9.3 Sales, Revenue and Market Share of Sickle Cell Disease Drug
      • 10.9.4 Sickle Cell Disease Drug Product Introduction
      • 10.9.5 Bristol-Myers Squibb Co Recent Development
    • 10.10 Calimmune Inc
      • 10.10.1 Calimmune Inc Company Details
      • 10.10.2 Company Description and Business Overview
      • 10.10.3 Sales, Revenue and Market Share of Sickle Cell Disease Drug
      • 10.10.4 Sickle Cell Disease Drug Product Introduction
      • 10.10.5 Calimmune Inc Recent Development
    • 10.11 CRISPR Therapeutics
    • 10.12 CSL Ltd
    • 10.13 Daiichi Sankyo Co Ltd
    • 10.14 Editas Medicine Inc
    • 10.15 Errant Gene Therapeutics LLC
    • 10.16 Gamida Cell Ltd
    • 10.17 Genethon SA
    • 10.18 Gilead Sciences Inc
    • 10.19 Global Blood Therapeutics Inc

    11 Value Chain and Sales Channels Analysis

    • 11.1 Value Chain Analysis
    • 11.2 Sales Channels Analysis
      • 11.2.1 Sickle Cell Disease Drug Sales Channels
      • 11.2.2 Sickle Cell Disease Drug Distributors
    • 11.3 Sickle Cell Disease Drug Customers

    12 Market Forecast

    • 12.1 Global Sickle Cell Disease Drug Sales and Revenue Forecast 2019-2025
    • 12.2 Global Sickle Cell Disease Drug Sales Forecast by Type
    • 12.3 Global Sickle Cell Disease Drug Sales Forecast by Application
    • 12.4 Sickle Cell Disease Drug Forecast by Regions
      • 12.4.1 Global Sickle Cell Disease Drug Sales Forecast by Regions 2019-2025
      • 12.4.2 Global Sickle Cell Disease Drug Revenue Forecast by Regions 2019-2025
    • 12.5 United States Market Forecast
    • 12.6 European Union Market Forecast
    • 12.7 China Market Forecast
    • 12.8 Rest of World
      • 12.8.1 Japan
      • 12.8.2 Korea
      • 12.8.3 India

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Research Methodology
        • 14.1.1 Methodology/Research Approach
          • 14.1.1.1 Research Programs/Design
          • 14.1.1.2 Market Size Estimation
          • 14.1.1.3 Market Breakdown and Data Triangulation
        • 14.1.2 Data Source
          • 14.1.2.1 Secondary Sources
          • 14.1.2.2 Primary Sources
      • 14.2 Author Details

      In 2019, the market size of Sickle Cell Disease Drug is million US$ and it will reach million US$ in 2025, growing at a CAGR of from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
      In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Sickle Cell Disease Drug.

      This report studies the global market size of Sickle Cell Disease Drug, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
      This study presents the Sickle Cell Disease Drug sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
      For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

      In global market, the following companies are covered:
      Acceleron Pharma Inc
      Addmedica SAS
      Angiocrine Bioscience Inc
      Annexin Pharmaceuticals AB
      ArQule Inc
      Bio Products Laboratory Ltd
      Bioverativ Inc
      bluebird bio Inc
      Bristol-Myers Squibb Co
      Calimmune Inc
      CRISPR Therapeutics
      CSL Ltd
      Daiichi Sankyo Co Ltd
      Editas Medicine Inc
      Errant Gene Therapeutics LLC
      Gamida Cell Ltd
      Genethon SA
      Gilead Sciences Inc
      Global Blood Therapeutics Inc

      Market Segment by Product Type
      ARQ-092
      BIVV-003
      CAL-H
      CTX-001
      DRX-194
      Others

      Market Segment by Application
      Hospital
      Clinic
      Others

      Key Regions split in this report: breakdown data for each region.
      United States
      China
      European Union
      Rest of World (Japan, Korea, India and Southeast Asia)

      The study objectives are:
      To analyze and research the Sickle Cell Disease Drug status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
      To present the key Sickle Cell Disease Drug manufacturers, presenting the sales, revenue, market share, and recent development for key players.
      To split the breakdown data by regions, type, companies and applications
      To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
      To identify significant trends, drivers, influence factors in global and regions
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

      In this study, the years considered to estimate the market size of Sickle Cell Disease Drug are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      Buy now